2022 APTA Honors and Awards Program

APTA's Honors and Awards program celebrates outstanding achievements on the part of association members in the areas of overall accomplishment, education, practice and service, publications, research, and academic excellence. APTA has announced the 2022 Honors and Awards Program recipients, and it is our pleasure to announce that the following member from APTA Colorado has been selected to receive the following award:

Catherine Worthingham Fellow of the American Physical Therapy Association

  • Michael Harris-Love, PT, MPT, DSc, FAPTA

Award recipients will be recognized with a ceremony and a reception hosted by the PT Fund on Sunday, Aug. 14, in Washington D.C. at the Omni Shoreham Hotel. The Honors & Awards Ceremony will immediately follow the 27th John H.P. Maley Lecture beginning at 7:00 pm E.T.

 

2022 APTA House of Delegates Motions Posted

The House will consider 22 motions during upcoming virtual and in-person meetings.

APTA members can now access the first official packet of motions that will be considered by the 2022 APTA House of Delegates when it convenes beginning on July 30 in a virtual format and continuing August 14-15 in Washington, D.C.

Called "Packet I," the compilation contains 22 motions set to be forwarded to this year’s House of Delegates.

Motions are developed by delegates and include support statements that describe the expected outcome of the motion if adopted and how it contributes to achieving APTA’s vision. Over the coming months, delegates will ask clarifying questions of motion makers, and the language for many motions may continue to evolve even during House deliberation. Delegates then vote for or against these motions with final decisions reported via the official minutes.

Delegates should continue using the Motion Information forum in the House of Delegates online Hub community to share information and ask clarifying questions. Chief, section, and assembly delegates wishing to cosponsor a motion or request that a motion be placed on consent should visit the House Motions, House Reports, and Additional Resources file library.

Please direct questions to [email protected]. Full article

 

CMS Updates Guidance Related to Emergency Preparedness R/T the Ongoing PHE

From CHAP

CMS’s Quality, Safety & Oversight Group posted Revised Memo on May 26, 2022, which provides updated guidance for surveyors and providers about emergency preparedness training and testing program exemptions and assessment of compliance with the EP requirements. (Guidance related to Emergency Preparedness- Exercise Exemption based on A Facility's Activation of their Emergency Plan (Ref: QSO-20-41-ALL, Revised 5/26/2022))

This updated guidance only applies if a facility/provider is still currently operating under its activated emergency plan or reactivated its emergency plan for COVID-19 in 2021 or 2022.

If your organization has resumed normal operating status (not under their activated emergency plans), you are required to conduct testing exercises based on the regulatory requirements for their specific provider or supplier type. 

Background: The emergency preparedness regulations allow an exemption for providers or suppliers that experience a natural or man-made event requiring activation of their emergency plan. On Friday, March 13, 2020, the President declared a national emergency due to COVID-19 and subsequently many providers and suppliers have activated their emergency plans to address surge and coordinate response activities. Facilities that activate their emergency plans are exempt from the next required full-scale community-based or individual, facility-based functional exercise. Facilities must be able to demonstrate, through written documentation, that they activated their program due to the emergency.

Updated guidance key points:

  • CMS recognizes many facilities are still operating under disaster/emergency conditions during the PHE, (e.g., under an activated emergency plan), so they are providing additional guidance for inpatient and outpatient providers/suppliers, consistent with the exemption authorized by the EP regulations. 
  • This guidance provides clarifications on testing exemptions for those providers/suppliers who continue to operate under their activated emergency plan and those which may have reactivated their emergency plans for COVID-19. 
  • This exemption applies to the next required full-scale exercise only, not the exercise of choice, based on the facility's 12-month exercise cycle. 
    • The exercise cycle is determined by the facility (e.g., calendar year, fiscal year or another 12-month timeframe).

This guidance will also apply for any subsequent 12-month cycles in the future, in the event facilities continue to operate under their activated emergency plans for COVID-19 response activities.

 

Monkeypox Virus Infection in the United States and Other Non-endemic Countries—2022

Cases of monkeypox have previously been identified in travelers from, or residents of, West African or Central African countries where monkeypox is considered to be endemic. CDC is issuing this Health Alert Network (HAN) Health Advisory to ask clinicians in the United States to be vigilant to the characteristic rash associated with monkeypox. Suspicion for monkeypox should be heightened if the rash occurs in people who 1) traveled to countries with recently confirmed cases of monkeypox, 2) report having had contact with a person or people who have a similar appearing rash or received a diagnosis of confirmed or suspected monkeypox, or 3) is a man who regularly has close or intimate in-person contact with other men, including those met through an online website, digital application (“app”), or at a bar or party. Lesions may be disseminated or located on the genital or perianal area alone. Some patients may present with proctitis, and their illness could be clinically confused with a sexually transmitted infection (STI) like syphilis or herpes, or with varicella zoster virus infection. Read the full report at Monkeypox Virus Infection in the United States

Additional information on Monkeypox can be found here: Monkeypox | Poxvirus | CDC 

 

COVID-19 Booster Now Available for Children Aged 5-11 Years

The U.S. Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) recently authorized and endorsed a single booster dose of the Pfizer-BioNTech COVID-19 vaccine for children aged 5-11 years at least five months after completion of a Pfizer-BioNTech COVID-19 vaccine primary series. The Centers for Medicare & Medicaid Services (CMS) will continue to ensure that coverage is available for this critical protection from the virus that causes COVID-19, including this new booster dose, without cost sharing.

The best way to protect yourself and your children from COVID-19 is to get vaccinated. Parents, if you have not gotten vaccinated, or have not taken your children to get vaccinated, now is the time. Continued safety monitoring shows that the COVID-19 vaccines are safe for children and teens. In addition, they are effective at preventing severe illness from infection with the virus.

CMS is helping to ensure that cost is not a barrier to access, including for boosters. The federal government is providing vaccines free of charge to everyone 5 years and older living in the United States, regardless of their immigration or health insurance status. People can visit vaccines.gov (English) or vacunas.gov (Spanish) to search for vaccines nearby.

CMS continues to explore ways to ensure maximum access to COVID-19 vaccinations and boosters. There are numerous resources available. Organizations can use the free, customizable materials from the web available through this web page CMS COVID-19 web page. This important information can be utilized in their outreach efforts year-round, including digital videos, palm cards, posters, infographics, social media messages, graphics, and more.

Please share these materials, bookmark these pages, and check back often for the most up-to-date information. It is important to us that we help encourage our beneficiaries and consumers –especially those with chronic conditions – to protect themselves and their loved ones from COVID-19.

 
<< first < Prev 51 52 53 54 55 56 57 58 59 60 Next > last >>

Page 52 of 172